(2026). Successful Co‐Administration of Secukinumab and Dupilumab in a Patient With Psoriasis and Paradoxical Atopic Dermatitis. JEADV Clinical Practice.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Successful Co‐Administration of Secukinumab and Dupilumab in a Patient With Psoriasis and Paradoxical Atopic Dermatitis."
JEADV Clinical Practice 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Successful Co‐Administration of Secukinumab and Dupilumab in a Patient With Psoriasis and Paradoxical Atopic Dermatitis."
JEADV Clinical Practice, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.